Vivex Biomedical, Inc. — Form D/A

Vivex Biomedical, Inc. of ATLANTA, GA, a company, filed a Form D amendment with the SEC on 2013-09-16. The offering totals $7.2M, of which $7.2M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (34)

Showing 25 of 34 people.

NameRoleLocation
Tracy AndersonDirectorLos Angeles, CA
Saadiq Thomas El-Amin, IIIDirectorMarietta, GA
David R GreenbergDirectorMarietta, GA
Thomas A GreeneDirectorMarietta, GA
Timothy LusbyDirectorMarietta, GA
John Bertram McCallumDirectorMarietta, GA
Jouko R RissanenDirectorMarietta, GA
TIMOTHY TAYLORDirectorNew York, NY
H. Thomas TempleDirectorMarietta, GA
Tracy AndersonExecutive OfficerLos Angeles, CA
John MarshExecutive OfficerHouston, TX
Holly MasonExecutive OfficerMarietta, GA
Michael RozmajzlExecutive OfficerMilton, GA
Jeffrey A SmithDirectorCarrollton, GA
THOMAS J GIBSONExecutive OfficerATLANTA, GA
Richard E PerlmanDirectorCHICAGO, IL
James K PriceDirectorCHICAGO, IL
Timothy Thomas Ganey, Ph.D.Executive OfficerAtlanta, GA
Holly S MasonExecutive OfficerAtlanta, GA
John A McCallumDirectorAtlanta, GA
Barry Thomas SalzmanDirectorAtlanta, GA
Dr. H Thomas TempleExecutive OfficerAtlanta, GA
Tracy S AndersonDirectorAtlanta, GA
Tracy S AndersonExecutive OfficerAtlanta, GA
J. Miguel Fernandez de CastroDirectorAtlanta, GA

Other filings by this issuer (4)

FiledFormOfferingSold
2017-05-11D/A$7.0M$6.3M
2017-01-26D$5.0M
2016-01-05D$10.0M$6.6M
2013-07-18D$5.5M$2.2M

More